IT services for pharmaceutical and life sciences in Hyderabad
Hyderabad is one of India's principal pharmaceutical centres, with bulk drug and formulation plants concentrated around the Patancheru and Jeedimetla belts and research operations clustered north of the city. What separates pharma IT from general manufacturing is documentation: here, an undocumented change is a finding, regardless of whether it worked.
The systems pharma manufacturers, CROs and life sciences companies actually run
Support only works if the provider knows what is on the network. This is the stack we expect to find, and the one we scope against.
- ERP and quality management systems holding batch records
- Laboratory instruments with attached workstations, frequently validated and version-locked
- LIMS handling sample tracking and results
- Document management for SOPs, with controlled issue and revision history
- Environmental monitoring and building management systems
- Regulated storage for electronic records and signatures
What constrains IT decisions in pharmaceutical and life sciences
- Data integrity expectations
- Regulated records are assessed against attributable, legible, contemporaneous, original and accurate principles. Audit trails must be enabled, protected from alteration and reviewable, which places real requirements on system configuration and access control.
- Computer system validation
- Systems in regulated use are validated for their intended purpose. A patch, a driver update or a server move is a change that needs assessment and documentation rather than a Tuesday maintenance task.
- 21 CFR Part 11 for export-facing operations
- Sites supplying regulated markets work to electronic records and signatures requirements, which govern access controls, audit trails and record retention in ways general IT practice does not.
What we find going wrong
These are the recurring failures across the pharmaceutical and life sciences estates we have taken on. If several of them are familiar, the pattern is more common than it feels.
- Audit trails disabled or never enabled on a validated system, discovered during an inspection
- IT changes made without a change record, so the validated state cannot be demonstrated
- Instrument workstations on unsupported operating systems with no isolation
- Backups of regulated records that have never been restore-tested, so retention cannot be evidenced
- Shared or generic accounts on systems where actions must be attributable to a person
How we deal with each of those
Audit trails disabled or never enabled on a validated system, discovered during an inspection. We find it during the audit and fix it before it becomes an incident, rather than discovering it in a post-mortem. For pharma manufacturers, CROs and life sciences companies that matters because data integrity expectations leaves very little room when audit trails disabled or never enabled on a validated system is the thing that fails.
IT changes made without a change record, so the validated state cannot be demonstrated. It goes into the monitored baseline, so the failure is caught by an alert instead of by a user. For pharma manufacturers, CROs and life sciences companies that matters because computer system validation leaves very little room when iT changes made without a change record is the thing that fails.
Instrument workstations on unsupported operating systems with no isolation. We remediate it and then document the control, so it can be evidenced rather than asserted. For pharma manufacturers, CROs and life sciences companies that matters because 21 cfr part 11 for export-facing operations leaves very little room when instrument workstations on unsupported operating systems with no isolation is the thing that fails.
Backups of regulated records that have never been restore-tested, so retention cannot be evidenced. It becomes a scheduled, owned task under the contract rather than nobody in particular being responsible for it. For pharma manufacturers, CROs and life sciences companies that matters because data integrity expectations leaves very little room when backups of regulated records that have never been restore-tested is the thing that fails.
Shared or generic accounts on systems where actions must be attributable to a person. We design it out, because responding to the same fault repeatedly costs more than fixing the cause once. For pharma manufacturers, CROs and life sciences companies that matters because computer system validation leaves very little room when shared or generic accounts on systems where actions must be attributable to a person is the thing that fails.
What the first weeks look like
Nothing gets changed in the first phase. We document: what systems exist, which are validated, where audit trails are enabled, and what the current change history looks like. That baseline is agreed with your quality function before we touch anything, because on a regulated site an undocumented improvement is worse than a known gap. Remediation is then raised as changes, in your process, at your pace.
Nothing is quoted from a rate card. We audit the estate, tell you plainly what we found, and price the work the audit justifies. If part of it is not worth doing, we say so at the quoting stage rather than after you have paid for it.
What we deliver for pharmaceutical and life sciences
- Change control that fits your QMS
- IT changes raised, assessed and recorded in a form your quality function accepts, rather than performed and described later.
- Validated-system isolation
- Instrument and validated workstations segmented and monitored, so they can stay at their qualified version safely.
- Audit trail and access review
- Audit logging verified as enabled and protected, with periodic access reviews documented.
- Evidenced backup and retention
- Backup of regulated records with scheduled restore tests and written evidence of each one.
- Named accounts throughout
- Generic logins eliminated, multi-factor authentication applied, and joiner-mover-leaver handled as a documented process.
- Inspection-ready documentation
- Network diagrams, asset registers and procedures maintained continuously, so an inspection is not a scramble.
When we can touch your systems
Nothing on a validated system changes without a raised and approved change record. Routine work on non-regulated infrastructure runs to a normal schedule agreed with your quality team.
Managed clients have a 30-minute response target for critical issues. For a first enquiry, we reply within 4 business hours.
IT for pharmaceutical and life sciences, answered
Pharmaceutical and life sciences across Hyderabad
Areas where this sector concentrates, and where we already work.
Services that fit pharmaceutical and life sciences
The parts of what we do that this sector buys most often.
Get a fixed-scope quote for pharmaceutical and life sciences
Tell us what you run and where, and we will come back within 4 business hours. Managed clients get a 30-minute response SLA.